6841 - 6850 of 9036 Results
Title
Year
- End of life planning in parkinsonian diseases2019RESTRICTEDTitle: End of life planning in parkinsonian diseasesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.026Citation Count: 10
-
OPENTitle: APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodiesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 10Start Page: e70795End Page: e70795Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.70795Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70795Citation Count: 0
-
OPENTitle: Hypoxic conditioning in Parkinson’s disease: randomized controlled multiple N-of-1 trialsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 8469End Page: 8469Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-025-63324-2Best OA location URL: https://www.nature.com/articles/s41467-025-63324-2.pdfCitation Count: 3
-
OPENTitle: The deterministic role of 5-mers in microRNA-gene targetingJournal Name: RNA BiologyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2018.1462652Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2018.1462652?needAccess=trueCitation Count: 16
- Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease2020OPENTitle: Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 851End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27993Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27993Citation Count: 50
-
OPENTitle: Missing Drivers with Dementia: Antecedents and RecoveryJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 60Issue #: 11Start Page: 2063End Page: 2069Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/j.1532-5415.2012.04159.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1532-5415.2012.04159.xCitation Count: 22
- CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?2022RESTRICTEDTitle: CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 886End Page: 890Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28998Citation Count: 3
- In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies2024RESTRICTEDTitle: In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 130-131Issue #:Start Page: 108891End Page: 108891Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nucmedbio.2024.108891Citation Count: 12
-
OPENTitle: Cardiac sympathetic denervation and anxiety in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 124Issue #:Start Page: 106997End Page: 106997Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106997Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11893108/pdf/nihms-2058597.pdfCitation Count: 8
-
OPENTitle: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104525End Page: 104525Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104525Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104525Citation Count: 107